http://rdf.ncbi.nlm.nih.gov/pubchem/reference/3142861

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, Non-U.S. Gov't|Review
endingPage 3514
issn 1381-6128
issueIdentifier 32
pageRange 3506-3514
publicationName Current Pharmaceutical Design
startingPage 3506
bibliographicCitation Dolezal M, Kesetovic D, Zitko J. Antimycobacterial evaluation of pyrazinoic acid reversible derivatives. Curr Pharm Des. 2011;17(32):3506–14. doi: 10.2174/138161211798194477. PMID: 22074423.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_53d454761b405b6dd0090ccdaa07db3f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7fba0470bfa5b8ac977cec60ff6ec364
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_69e9c491ebc9cfab6817a1c830916774
date 2011-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.2174/138161211798194477
https://pubmed.ncbi.nlm.nih.gov/22074423
isPartOf https://portal.issn.org/resource/ISSN/1381-6128
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21197
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Antimycobacterial Evaluation of Pyrazinoic Acid Reversible Derivatives
discusses http://id.nlm.nih.gov/mesh/M0046746
http://id.nlm.nih.gov/mesh/M0018224
http://id.nlm.nih.gov/mesh/M0017642
http://id.nlm.nih.gov/mesh/M0448397
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9261
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1046
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1047

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128707817
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128453609
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128200310

Total number of triples: 30.